TABLE 2.
Protein | Position | Residue | Phenotype(s) |
---|---|---|---|
Capsid | 106 | Ala | Enhanced infectivity and fitness in mosquitoes and IFNAR KO mice (32, 35) |
prM | 123 | Val | Enhanced infectivity in mosquito cells; increased frequency of fetal demise in IFNAR KO mice (36) |
prM | 139 | Asn | Enhanced infectivity in human and murine neural progenitor cells; increased microcephaly severity in BALB/c mice (37) |
Envelope | 443 | Asn | Enhanced infectivity and virulence in IFNAR KO mice and mosquitoes; reduced infectivity and entry into mosquito cells; reduced neurovirulence in BALB/c mice (83, 84, 115, 116) |
NS1 | 982 | Val | Increased NS1 antigenemia and infectivity in mosquitoes; enhanced ability to block IFN induction (31, 85) |
Columns 1 to 3 indicate the viral protein, position relative to the viral polyprotein, and amino acid residue, respectively. Column 4 describes the phenotype associated with the specific amino acid residue as previously demonstrated.